In the TME, this cells population is expanded in response to various tumor-derived factors, including IL-4, IL-6, IL-13, and TGFβ, which impair the maturation of bone marrow-derived myeloid cells (BMDCs) into antigen-presenting cells (APCs) [84]. The gene discussed is TGFB1; the disease is neoplasm.